Takeda Announces New Assignments of Directors

Contributed by: Business Wire

Logo

Tags

Biotechnology

Pharmaceutical

Health

Oncology

New Assignments of Directors

More Like This

Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting

Takeda Announces Chief Financial Officer Succession

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries

Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting

Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion

Takeda Named Global Top Employer for Seventh Consecutive Year

Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance